Another week, another great news story about Alzheimer’s and the progress being made in current research:
This has to be yesterday’s most important & exciting news story on the potential benefits of the drug
#solanezumab http://www.theguardian.com/science/2015/jul/22/scientists-find-first-drug-slow-alzheimers-disease …
Dr Eric Karran, director of research at Alzheimer’s Research UK said:
“This is the first evidence of something genuinely modifying the disease process. It’s a breakthrough in my mind. The history of medicine suggests that once you get through that door you can explore further therapeutic opportunities much more aggressively. It makes us less helpless.”
We should be careful when using terms such as “a breakthrough,” but there does seem to be genuine excitement for the possibilities with the drug Solanezumab. It appears to be most effective when given to patients in the early stages of the disease. This of course will mean that for the greatest benefits to be possible then people will need to be diagnosed as early as possible in order to be able to benefit from this potential discovery. This will require funding not just for the research itself, but for the support services around diagnoses – GP’s, follow-up clinics etc.
There will undoubtedly be more stories like this over the coming months and years. It just goes to show the importance of research and the need for this to be properly funded by Government.
This has been a good news week for Alzheimer’s – again! Long may we have many more in the future!